Journal Of Clinical Pharmacy And Therapeutics

Journal Of Clinical Pharmacy And Therapeutics

临床药学与治疗学杂志

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Journal Of Clinical Pharmacy And Therapeutics》是由Wiley-Blackwell Publishing Ltd出版社于1987年创办的英文国际期刊(ISSN: 0269-4727,E-ISSN: 1365-2710),该期刊长期致力于药学领域的创新研究,主要研究方向为医学-药学。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0846...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比76.36%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在55篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Journal Of Clinical Pharmacy And Therapeutics审稿周期约为 偏慢,4-8周 。该刊近年未被列入国际预警名单,年发文量约55篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 55 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 210 / 354

40.8%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 253 / 354

28.67%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:4.1 SJR:0.569 SNIP:0.659
学科类别 分区 排名 百分位
大类:Medicine 小类:Pharmacology (medical) Q2 122 / 272

55%

大类:Medicine 小类:Pharmacology Q3 170 / 313

45%

期刊发文

  • Comparation of vancomycin penetration into cerebrospinal fluid in postoperative intracranial infection and community-acquired meningitis patients.

    Author: Cai Y1, Zhou L2, Wang H3, Zhang L1, Wang J1, Zhang K1.

    Journal: J Clin Pharm Ther. 2019 Apr;44(2):216-219. doi: 10.1111/jcpt.12770. Epub 2018 Oct 27.

  • Recognition of the toxicity of aristolochic acid.

    Author: Zhang HM1, Zhao XH2, Sun ZH1, Li GC3, Liu GC4, Sun LR1, Hou JQ5, Zhou W1.

    Journal: J Clin Pharm Ther. 2019 Apr;44(2):157-162. doi: 10.1111/jcpt.12789. Epub 2018 Dec 11.

  • Association between aripiprazole pharmacokinetics and CYP2D6 phenotypes: A systematic review and meta-analysis.

    Author: Zhang X1, Xiang Q1, Zhao X1, Ma L1, Cui Y1.

    Journal: J Clin Pharm Ther. 2019 Apr;44(2):163-173. doi: 10.1111/jcpt.12780. Epub 2018 Dec 18.

  • Similarity-based machine learning support vector machine predictor of drug-drug interactions with improved accuracies.

    Author: Song D1,2, Chen Y3, Min Q3, Sun Q3, Ye K4, Zhou C3, Yuan S3, Sun Z2, Liao J3,5.

    Journal: J Clin Pharm Ther. 2019 Apr;44(2):268-275. doi: 10.1111/jcpt.12786. Epub 2018 Dec 18.

  • Tumour necrosis factor-α gene -308 G > A and -238 G > A polymorphisms are associated with susceptibility to irritable bowel syndrome and drug efficacy in children.

    Author: Sun MH1, Sun LQ1, Guo GL2, Zhang S1.

    Journal: J Clin Pharm Ther. 2019 Apr;44(2):180-187. doi: 10.1111/jcpt.12775. Epub 2018 Dec 21.

  • Comparison of efficacy and safety between febuxostat and allopurinol in early post-renal transplant recipients with new onset of hyperuricemia.

    Author: Shen X1,2, Li J3, Fu Q4, Liu L4, Gao X1, Chen X1, Chen P1, Wang C4.

    Journal: J Clin Pharm Ther. 2019 Apr;44(2):318-326. doi: 10.1111/jcpt.12794. Epub 2018 Dec 23.

  • Genotype-guided dosing versus conventional dosing of warfarin: A meta-analysis of 15 randomized controlled trials.

    Author: Yang T1, Zhou Y1, Chen C1, Lu M1, Ma L1, Cui Y1.

    Journal: J Clin Pharm Ther. 2019 Apr;44(2):197-208. doi: 10.1111/jcpt.12782. Epub 2018 Dec 28.

  • Population pharmacokinetics and dose simulation of oxcarbazepine in Chinese paediatric patients with epilepsy.

    Author: Chen CY1, Zhou Y1,2, Cui YM1,2, Yang T1, Zhao X1,2, Wu Y3.

    Journal: J Clin Pharm Ther. 2019 Apr;44(2):300-311. doi: 10.1111/jcpt.12792. Epub 2019 Jan 12.